NKp44 was similarly able to inhibit IFNα production by pDCs stimulated by SLE anti-DNA immunocomplexes and, remarkably, consistently synergized with LAIR-1 for inhibiting IFNα release. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.